JAGX - Jaguar Health Inc
IEX Last Trade
1.135
0.015 1.322%
Share volume: 172,775
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.12
0.02
1.34%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-22 | 2022-11-14 | 2023-03-24 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-04-01 | 2024-05-14 | |
Total revenue | 2.921 M | 3.150 M | 3.260 M | 1.972 M | 2.676 M | 2.813 M | 2.300 M | 2.351 M | |
Cost of revenue | 456.000 K | 613.000 K | 495.000 K | 345.000 K | 491.000 K | 514.000 K | 687.000 K | 430.000 K | |
Gross profit | 2.465 M | 2.537 M | 2.765 M | 1.627 M | 2.185 M | 2.299 M | 1.613 M | 1.921 M | |
2.92% | 8.99% | -41.16% | 34.30% | 5.22% | -29.84% | 19.09% | |||
Operating expenses | 8.944 M | 12.433 M | 9.051 M | 11.472 M | 10.287 M | 11.086 M | 8.799 M | 10.136 M | |
Selling general and admin | 6.493 M | 6.493 M | 4.740 M | 6.697 M | 6.010 M | 5.005 M | 5.336 M | 5.824 M | |
Research and development | 2.451 M | 5.940 M | 4.311 M | 4.775 M | 4.277 M | 6.081 M | 3.463 M | 4.312 M | |
Total expenses | 9.400 M | 13.046 M | 9.546 M | 11.817 M | 10.778 M | 11.600 M | 9.486 M | 10.566 M | |
38.79% | -26.83% | 23.79% | -8.79% | 7.63% | -18.22% | 11.39% | |||
Operating income | -6.479 M | -9.896 M | -6.286 M | -9.845 M | -8.102 M | -8.787 M | -7.186 M | -8.215 M | |
Ebit | -6.479 M | -9.896 M | -6.286 M | -9.845 M | -8.102 M | -8.787 M | -7.186 M | -8.215 M | |
Pretax income | -9.390 M | -12.609 M | -8.232 M | -12.397 M | -12.291 M | -7.904 M | -9.309 M | -9.368 M | |
34.28% | -34.71% | 50.60% | -0.86% | -35.69% | 17.78% | 0.63% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -9.367 M | -12.520 M | -7.581 M | -12.202 M | -12.150 M | -7.778 M | -9.170 M | -9.226 M | |
-33.66% | 39.45% | -60.96% | 0.43% | 35.98% | -17.90% | -0.61% | |||
Net income | -9.367 M | -12.520 M | -7.581 M | -12.202 M | -12.150 M | -7.778 M | -9.170 M | -9.226 M | |
-33.66% | 39.45% | -60.96% | 0.43% | 35.98% | -17.90% | -0.61% |